The Savvygen™ STI MG/MH allows the qualitative detection of Mycoplasma genitalium (MG) and Mycoplasma hominis (MH) by Real- time PCR in urine or from vaginal swab specimen. The test is intended to be used as an aid in the diagnosis of Mycoplasma genitalium and Mycoplasma hominis infections, in both symptomatic and asymptomatic individuals.

According to the World Health Organization (WHO) more than 340 million new cases of sexually transmitted bacterial and protozoan infections occur throughout the world every year. Sexually transmitted diseases (STDs) also known as Sexually Transmitted Infections (STIs) consist of diseases that are spread primarily through person-to-person sexual contact. STIs represent a significant public health concern. Although many STIs remain asymptomatic or do not exhibit clear and distinctive symptoms, such infections may result in acute symptoms as well as other severe delayed consequences such as infertility, ectopic pregnancy, cervical cancer and death. These diseases are caused by more than 30 pathogenic viruses, bacteria and parasites (1). Furthermore, infection by STDs increases substantially the potential of acquiring or transmitting human immunodeficiency virus HIV. Such interaction could account for 40% or more of HIV transmissions. The Savvygen™ STI MG/MHwas developed in order to detect two of the most common sexually transmitted pathogens- Mycoplasma genitalium (MG) and Mycoplasma hominis (MH).


  • Ready-to-use master mixes
  • Panels can be tested separately or all together
  • Short RT-thermocyclers protocol
  • Full compatibility with the most common RT-thermocyclers
  • Integrated internal controls guarantee appropriate validated results
  • Sample types – Urine & urogenital swabs


Catalog No Product name Tests/kit Approvals
615-01 Savvygen STI MG/MH 48 CE